Streetbeat News

ENDPQ

Endo International plc

www.endo.com

CEO

Blaise Coleman

Employees

3,103

Industry

Pharmaceutical Preparation Manufacturing

Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Endo International (OTC:ENDPQ), a bankrupt generic drugmaker, has received court approval to solicit votes for its restructuring plan, which includes a $600 million trust to compensate various creditors affected by the opioid epidemic linked to its painkiller Opana ER. The plan is still under negotiation with U.S. agencies and proposes payments of up to $465 million over ten years. A group of states, tribes, and private institutions is supporting the vote solicitation, indicating progress in discussions with the U.S. Trustee and the Department of Justice.

Portfolio Pulse from Vandana Singh

January 11, 2024 | 7:09 pm

Endo International's lenders have proposed a $465 million settlement with U.S. government agencies to resolve disputes over the company's restructuring plan during its ongoing bankruptcy proceedings. The plan includes a $365 million payment over ten years or a $200 million lump sum, with an additional $100 million in unsecured notes based on future performance. This proposal aims to help Endo exit Chapter 11 bankruptcy and facilitate compensation for opioid victims.

Portfolio Pulse from Vandana Singh

November 22, 2023 | 11:56 am

Rite Aid Corp (NYSE:RAD) is reportedly on the brink of bankruptcy due to its role in the opioid crisis and a significant debt burden exceeding $3.3 billion. The company is facing numerous lawsuits and has seen its stock value drop by over 80% within a year. Other pharmaceutical companies like Purdue Pharma, Mallinckrodt Plc (NYSE:MNK), and Endo International Plc (OTC:ENDPQ) have also faced bankruptcy due to opioid-related litigations.

Portfolio Pulse from Vandana Singh

August 25, 2023 | 5:52 pm

Endo International plc (OTC:ENDPQ) and Premier, Inc. (NASDAQ:PINC) have announced a collaboration to address the shortage of Pitocin, a critical labor and delivery drug. Endo's Par Sterile Products business will supply Pitocin vials through Premier's ProvideGx and PremierProRx programs. The partnership aims to provide a stable product supply and enhance pricing predictability.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 8:32 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.